2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene has been researched along with dicyclomine in 1 studies
Studies (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Trials (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Recent Studies (post-2010) (2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene) | Studies (dicyclomine) | Trials (dicyclomine) | Recent Studies (post-2010) (dicyclomine) |
---|---|---|---|---|---|
10 | 0 | 0 | 398 | 41 | 74 |
Protein | Taxonomy | 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene (IC50) | dicyclomine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.468 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.046 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0029 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0024 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0035 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0044 | |
Histamine H2 receptor | Homo sapiens (human) | 1.625 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.24 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.468 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.21 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.301 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 3.065 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0049 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
1 other study(ies) available for 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene and dicyclomine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |